|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | sAPP Beta-w (Highly Sensitive) ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Bevacizumab (Avastin®) ELISA | C-Peptide ELISA Assay | GLP-1, Active Form (High Sensitivity) ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27732 | TM09036 | TM09010 | IB79101 | 27700 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination human sAPPß-w in EDTA plasma, cerebrospinal fluids and cell culture supernatant. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Solid phase enzyme immunoassay (ELISA) for the determination of C-Peptide in serum, plasma and urine. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of GLP-1 (Active Form) in human, mouse and rat EDTA-plasma, and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Bordetella pertussis IgM | sAPP Total | Bevacizumab (Avastin®) | Dopamine | Metanephrine / Normetanephrine |
| Sample Type | Serum, Blood Plasma | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum and plasma. | Tissue Homogenates, Dialysates, Urine | Urine |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0.78 to 50 ng/mL | Anti-Ustekinumab (Stelara®) | 0 / 6 to 200 ng/mL | 0.2 to 16.0 ng/mL | 0.25 to 16 pmol/L |
| Sensitivity | 89.19 % (95% confidence interval: 74.58% - 96.97%) | 0.06 ng/mL | 2 ng/mL | 0.25 ng/mL x C (must be multipled by a correction factor dependent on sample volume). | Metanephrine: 8 ng/mL. Normetanephrine: 22 ng/mL. |
| Assay Time | Overnight + 1 hr (incubation) | 2 hour, 30 min. total incubation time. | 1 hour, 45 min. total incubation time. | 1 hr 50 mins (incubation) | Overnight + 1 hr 30 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |